|
1
|
Fearon K, Strasser F, Anker SD, et al:
Definition and classification of cancer cachexia: an international
consensus. Lancet Oncol. 12:489–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar NB, Kazi A, Smith T, et al: Cancer
cachexia: traditional therapies and novel molecular mechanism-based
approaches to treatment. Curr Treat Options Oncol. 11:107–117.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Donohoe CL, Ryan AM and Reynolds JV:
Cancer cachexia: mechanisms and clinical implications.
Gastroenterol Res Pract. 2011:6014342011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Argilés JM, Busquets S, Toledo M and
López-Soriano FJ: The role of cytokines in cancer cachexia. Curr
Opin Support Palliat Care. 3:263–268. 2009.
|
|
5
|
Gupta SC, Kim JH, Kannappan R, et al: Role
of nuclear factor κB-mediated inflammatory pathways in
cancer-related symptoms and their regulation by nutritional agents.
Exp Biol Med (Maywood). 236:658–671. 2011.
|
|
6
|
Clària J: Publication of a special issue:
resolution of acute inflammation and the role of lipid mediators.
Scientific World Journal. 10:1553–1555. 2010.PubMed/NCBI
|
|
7
|
Tan BH, Ross JA, Kaasa S, et al: European
Palliative Care Research Collaborative: Identification of possible
genetic polymorphisms involved in cancer cachexia: a systematic
review. J Genet. 90:165–177. 2011. View Article : Google Scholar
|
|
8
|
Argilés JM, Busquets S and López-Soriano
FJ: Anti-inflammatory therapies in cancer cachexia. Eur J
Pharmacol. 668(Suppl 1): S81–S86. 2011.
|
|
9
|
Batista ML Jr, Peres SB, McDonald ME, et
al: Adipose tissue inflammation and cancer cachexia: possible role
of nuclear transcription factors. Cytokine. 57:9–16. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiel A, Mrena J and Ristimäki A:
Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev.
30:387–395. 2011. View Article : Google Scholar
|
|
11
|
Turk HM, Camci C, Sevinc A, et al:
Cyclooxygenase-2 expression is not a marker of poor survival in
lung cancer. Asian Pac J Cancer Prev. 13:315–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Williams CS, Mann M and DuBois RN: The
role of cyclooxygenases in inflammation, cancer and development.
Oncogene. 18:7908–7916. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morita Y, Hata K, Nakanishi M, et al:
Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node
metastasis in oral squamous cell carcinoma. Int J Oncol.
41:885–892. 2012.PubMed/NCBI
|
|
14
|
Xin X, Majumder M, Girish GV, et al:
Targeting COX-2 and EP4 to control tumor growth, angiogenesis,
lymphangiogenesis and metastasis to the lungs and lymph nodes in a
breast cancer model. Lab Invest. 92:1115–1128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tisdale MJ: Cachexia in cancer patients.
Nat Rev Cancer. 2:862–871. 2002. View
Article : Google Scholar
|
|
16
|
Davis TW, Zweifel BS, O’Neal JM, et al:
Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced
wasting. J Pharmacol Exp Ther. 308:929–934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang SY, Yu H, Krygier JE, Wooley PH and
Mott MP: High VEGF with rapid growth and early metastasis in mouse
osteosarcoma model. Sarcoma. 2007:956282007.PubMed/NCBI
|
|
18
|
Evans WJ, Morley JE, Argilés J, et al:
Cachexia: a new definition. Clin Nutr. 27:793–799. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Serhan CN, Krishnamoorthy S, Recchiuti A
and Chiang N: Novel anti-inflammatory - pro-resolving mediators and
their receptors. Curr Top Med Chem. 11:629–647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao QT, Yue SQ, Cui Z, et al: Potential
involvement of the cyclooxygenase-2 pathway in hepatocellular
carcinoma-associated angiogenesis. Life Sci. 80:484–492. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seelaender M, Batista M Jr, Lira F,
Silverio R and Rossi-Fanelli F: Inflammation in cancer cachexia: to
resolve or not to resolve (is that the question?). Clin Nutr.
31:562–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Argilés JM, López-Soriano FJ and Busquets
S: Mechanisms to explain wasting of muscle and fat in cancer
cachexia. Curr Opin Support Palliat Care. 1:293–298.
2007.PubMed/NCBI
|
|
23
|
Lawrence T and Fong C: The resolution of
inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem
Cell Biol. 42:519–523. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patra SK and Arora S: Integrative role of
neuropeptides and cytokines in cancer anorexia-cachexia syndrome.
Clin Chim Acta. 413:1025–1034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Laviano A, Molfino A, Seelaender M, et al:
Carnitine administration reduces cytokine levels, improves food
intake, and ameliorates body composition in tumor-bearing rats.
Cancer Invest. 29:696–700. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weidle UH, Klostermann S, Eggle D and
Krüger A: Interleukin 6/interleukin 6 receptor interaction and its
role as a therapeutic target for treatment of cachexia and cancer.
Cancer Genomics Proteomics. 7:287–302. 2010.PubMed/NCBI
|
|
27
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shojaei F and Ferrara N: Antiangiogenesis
to treat cancer and intraocular neovascular disorders. Lab Invest.
87:227–230. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Krzystek-Korpacka M, Matusiewicz M,
Diakowska D, et al: Acute-phase response proteins are related to
cachexia and accelerated angiogenesis in gastroesophageal cancers.
Clin Chem Lab Med. 46:359–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kemik O, Sumer A, Kemik AS, et al: The
relationship among acute-phase response proteins, cytokines and
hormones in cachectic patients with colon cancer. World J Surg
Oncol. 8:852010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valcárcel M, Mendoza L, Hernández JJ, et
al: Vascular endothelial growth factor regulates melanoma cell
adhesion and growth in the bone marrow microenvironment via tumor
cyclooxygenase-2. J Transl Med. 9:1422011.PubMed/NCBI
|
|
32
|
Kim YY, Lee EJ, Kim YK, et al: Anti-cancer
effects of celecoxib in head and neck carcinoma. Mol Cells.
29:185–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
